In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting
- 1 August 1999
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 26 (6) , 687-693
- https://doi.org/10.1016/s0969-8051(99)00032-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Enhanced Binding and Inertness to Dehalogenation of α-Melanotropic Peptides Labeled Using N-Succinimidyl 3-IodobenzoateBioconjugate Chemistry, 1996
- Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.Proceedings of the National Academy of Sciences, 1995
- [111In]-DTPA-labeled analogues of α-melanocyte-stimulating hormone for melanoma targeting: Receptor bindingin vitro andin vivoInternational Journal of Cancer, 1994
- Cloning and Functional Characterization of a Family of Receptors for the Melanotropic PeptidesAnnals of the New York Academy of Sciences, 1993
- A chelating derivative of α-melanocyte stimulating hormone as a potential imaging agent for malignant melanomaBritish Journal of Cancer, 1990
- Potent and prolonged-acting cyclic lactam analogs of .alpha.-melanotropin: design based on molecular dynamicsJournal of Medicinal Chemistry, 1989
- Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.Proceedings of the National Academy of Sciences, 1988
- Approaches to Radiolabeling of Antibodies for Diagnosis and Therapy of CancerPharmaceutical Research, 1988
- Cyclic Melanotropins. 9. 7-D-Phenylalanine Analogues of the Active-Site SequenceJournal of Medicinal Chemistry, 1985
- Bombesin: Potent Effects on Thermoregulation in the RatScience, 1977